Jung-Yun Lee

79PUBLICATIONS
246CO-AUTHORS
Cancer diagnosisMolecular targetsPacific Peoples cultural determinants of healthPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Jul 24, 2026
Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients.

|May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

|Apr 28, 2026
Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.

|Apr 09, 2026
Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors.

Vicky Makker, Jung-Yun Lee, Do-Youn Oh

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 23, 2026
Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA.

Sung Jong Lee, Ji Geun Yoo, Jin Hwi Kim

Pageof 14

Frequent Collaborators

26 joint publications

Sang Wun Kim

24 joint publications

Sunghoon Kim

16 joint publications

Yong Jae Lee

15 joint publications

Young Tae Kim